A bipartisan group of lawmakers on Wednesday reintroduced a bill that would make the U.S. pharmaceutical supply chain less dependent on foreign countries like China. The legislation will help mitigate drug shortages while incentivizing the domestic production of drugs, active pharmaceutical ingredients (API), personal protective equipment (PPE), and diagnostics, according to Rep. Earl L. “Buddy” Carter (R-Ga.), one of…